Welcome To CZCF

Supply Nootropics Supplements Powder Nsi-189 Phosphate

Supply Nootropics Supplements Powder Nsi-189 Phosphate

Short Description:

Detail

Feedback

Payment&shipping

Overview
Quick Details
CAS No.:
1270138-40-3, 1270138-40-3
Other Names:
Nsi-189
MF:
C22H30N4O, C22H30N4O
EINECS No.:
-0
Place of Origin:
Jiangsu, China (Mainland)
Type:
Pharmaceutical Intermediates
Purity:
99.0%min
Brand Name:
CZCF
Model Number:
CZG
Application:
Pharm Intermediates
Appearance:
white powder
Product Name:
Nsi-189 Phosphate
Other Name:
Nsi-189
Form:
white powder
MW:
366.4998
Main function:
Improving momory
MOQ:
1 gram
Package:
Aluminum Bag
Sample:
1 gram

Supply Ability
1000 Kilogram/Kilograms per Month

Packaging & Delivery
Packaging Details
Aluminum Foil Bag or As your requirements
Port
Shanghai,Shenzhen

Lead Time :
Shipped in 2 days after payment


 

 
Changzhou Confucius

Supply Nootropics Supplements Powder Nsi-189 Phosphate 

 

 

 

 

Quick details:

 

Chemical name

NSI-189

CAS No.

1270138-40-3

Supplier

CZCF Biotech

Molecular Formula

C22H30N4O

Other name

(4-Benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone

Store at

Room temperature

Purity

99% min

Appearance

White to off white powder

 

 

Introduction:

 

NSI-189 is neurogenic and nootropic research agent that was developed from nicotinamide and pyrazine. Randomized controlled trials have shown that it stimulates neurogenesis or neuronal cell production in the brain. In animal studies, it has also been shown to increase the volume of hippocampus by 20% thereby reversing behavioral symptoms of depression. Such studies have shown that it may be an effective treatment for depression. It is also thought to be a promising treatment for other condition including post-traumatic stress disorder (PTSD), Alzheimer’s disease and age-related cognitive problems.

 

Function:

 

NSI-189 is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, an area of the brain believed to be contributory in MDD and other conditions, such as Alzheimer’s disease and Post-traumatic stress disorder (PTSD). Phase 1b of the clinical trial is to test the safety and tolerability of the depressed patients. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales: Linda Wang

 

Phone No.: 86 18861115106

Skype: 86 18861115106

Whatsapp: 86 18861115106

Wechat: 86 18861115106

 

ANY INQUIRY IS WELCOME! 

 

WITH US, YOUR MONEY IN SAFE, YOUR BUSINESS IN SAFE.

 

 

 


  • Previous:
  • Next:

  • feedback alibabafeedback

    shipping payment

    Write your message here and send it to us
    WhatsApp Online Chat !